Nanotherapeutics Advanced Development and Manufacturing (the NANO-ADM Center)

Summary

Nanotherapeutics Advanced Development and Manufacturing is a privately-held emerging biopharmaceutical company with expertise in pre-clinical and clinical development, formulation optimization, and cGMP manufacturing of vaccines, biopharmaceutical products, and medical devices. The facility provides research and quality control laboratories, BSL-3 bio-containment laboratories and production areas, pilot plant, warehouse, administration offices, and a conference center. Each function is zoned to allow for individual expansion. Production area utilities are fed from an interstitial space. Moses Engineering worked hand in hand with The Whiting-Turner Contracting Company who was the builder and RS&H who was chosen as the Architect to design this Advanced Development and Manufacturing Center based upon a depth of expertise in Health and Science facility design and the ability to work as a team member in this public-private partnership. The commissioning (Cx) process is an integrated set of activities intended to ensure that the project meets both the design goals and the owner’s operational requirements. An owner’s goals and objectives is what drives the project team. The value of Cx lies in its power to verify that those goals and objectives are met and that building systems perform as intended. The Cx Plan is a document that outlines the organization, schedule, allocation of resources, and documentation requirements of the Commissioning Process.